137 related articles for article (PubMed ID: 9595077)
1. Hyperacute allograft rejection mediated by IgM antibodies and a negative lymphocyte crossmatch: report of two cases.
Demirhan B; Karakayali H; Turan M; Güngen Y; Bilgin N
Transplant Proc; 1998 May; 30(3):732-3. PubMed ID: 9595077
[No Abstract] [Full Text] [Related]
2. Hyperacute rejection of living related kidney grafts caused by endothelial cell-specific antibodies: case reports.
Grandtnerová B; Mäcková N; Hovoricová B; Jahnová E
Transplant Proc; 2008 Sep; 40(7):2422-4. PubMed ID: 18790254
[TBL] [Abstract][Full Text] [Related]
3. Acute rejection and the flow cytometry crossmatch.
O'Malley KJ; Cook DJ; Roeske L; McCarthy JF; Klingman LL; Kapoor A; Hobart MG; Flechner SM; Modlin CS; Goldfarb DA; Novick AC
Transplant Proc; 1999; 31(1-2):1216-7. PubMed ID: 10083543
[No Abstract] [Full Text] [Related]
4. Effect of dithiothreitol on a variety of evolutive patterns of anti-T and -B lymphocyte antibodies in renal transplant candidates.
García de Masdevall MD; Arrieta A; Riñón M; Altés C; Arranz C
Transplant Proc; 1992 Dec; 24(6):2505-7. PubMed ID: 1465847
[No Abstract] [Full Text] [Related]
5. IgM antibodies in renal transplantation.
McCalmon RT; Tardif GN; Sheehan MA; Fitting K; Kortz W; Kam I
Clin Transplant; 1997 Dec; 11(6):558-64. PubMed ID: 9408684
[TBL] [Abstract][Full Text] [Related]
6. Weak humoral posttransplant alloresponse after a well-HLA-matched cadaveric kidney transplantation.
Matinlauri IH; Kyllönen LE; Eklund BH; Koskimies SA; Salmela KT
Transplantation; 2004 Jul; 78(2):198-204. PubMed ID: 15280678
[TBL] [Abstract][Full Text] [Related]
7. Rescue effect of FTY720 on acute renal rejection in dogs.
Yuzawa K; Otsuka M; Taniguchi H; Takada Y; Sakurayama N; Jinzenji Y; Suzuki S; Fukao K
Transplant Proc; 1999; 31(1-2):872. PubMed ID: 10083381
[No Abstract] [Full Text] [Related]
8. Biomarkers in transplantation: Prospective, blinded measurement of predictive value for the flow cytometry crossmatch after negative antiglobulin crossmatch in kidney transplantation.
Wen R; Wu V; Dmitrienko S; Yu A; Balshaw R; Keown PA;
Kidney Int; 2006 Oct; 70(8):1474-81. PubMed ID: 16941026
[TBL] [Abstract][Full Text] [Related]
9. Cadaveric kidney transplantation in patients with lymphocytotoxic autoantibodies.
Emonds MP; Dendievel J; Roels L; Waer M; Vanrenterghem Y; Vermylen C
Transplant Proc; 1992 Dec; 24(6):2502-3. PubMed ID: 1465845
[No Abstract] [Full Text] [Related]
10. [Humoral antibody-mediated rejection in kidney transplants].
Teraoka S; Kai K
Nihon Jinzo Gakkai Shi; 2005; 47(5):497-507. PubMed ID: 16130404
[No Abstract] [Full Text] [Related]
11. C4d deposition in early renal allograft protocol biopsies.
Koo DD; Roberts IS; Quiroga I; Procter J; Barnardo MC; Sutton M; Cerundolo L; Davies DR; Friend PJ; Morris PJ; Fuggle SV
Transplantation; 2004 Aug; 78(3):398-403. PubMed ID: 15316368
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of renal infiltrating cells following allograft nephrectomy.
Nikaein A; McQueen K; Boyer B; Landesberg R; Ryan DH; Insel RA
Transplant Proc; 1987 Feb; 19(1 Pt 1):398-400. PubMed ID: 3274792
[No Abstract] [Full Text] [Related]
13. Posttransplant antidonor antibodies and chronic rejection in renal transplantation.
Kimikawa M; Tojimbara T; Nakajima I; Fuchinoue S; Teraoka S; Toma H; Agishi T
Transplant Proc; 1999 Nov; 31(7):2872-3. PubMed ID: 10578321
[No Abstract] [Full Text] [Related]
14. Anti-class II antibodies in kidney transplant patients.
Rebibou JM; Bittencourt MC; Ducloux D; Chabod J; Thévenin C; Chalopin JM; Hervé P; Tiberghien P
Transplant Proc; 2000 Dec; 32(8):2748-9. PubMed ID: 11134785
[No Abstract] [Full Text] [Related]
15. Antibody and complement in graft rejection.
Sanfilippo F; Baldwin WM
Transplant Proc; 1997; 29(1-2):179-80. PubMed ID: 9122952
[No Abstract] [Full Text] [Related]
16. The liver allograft, chronic (ductopenic) rejection, and microchimerism: what can they teach us?
Demetris AJ; Murase N; Delaney CP; Woan M; Fung JJ; Starzl TE
Transplant Proc; 1995 Feb; 27(1):67-70. PubMed ID: 7879139
[No Abstract] [Full Text] [Related]
17. Influence of pretransplant antibodies on early renal allograft rejection.
Alarif L; Rodriguez R; Blackburn S; Light JA
Transplant Proc; 1987 Feb; 19(1 Pt 1):771-2. PubMed ID: 3274869
[No Abstract] [Full Text] [Related]
18. Relationship between macrophage infiltration of renal allografts and chronic renal impairment.
Yanagisawa T; Otsubo O; Shimada T; Nozaki H; Takahashi I; Inou T; Kuzuhara K; Hara S; Hara M; Onoda H; Wakabayashi T
Transplant Proc; 1997 Nov; 29(7):2783-6. PubMed ID: 9365562
[No Abstract] [Full Text] [Related]
19. Outcome of kidney transplants in patients known to be flow cytometry crossmatch positive.
Scornik JC; Clapp W; Patton PR; Van der Werf WJ; Hemming AW; Reed AI; Howard RJ
Transplantation; 2001 Apr; 71(8):1098-102. PubMed ID: 11374409
[TBL] [Abstract][Full Text] [Related]
20. Living-donor kidney transplant in T-cell and B-cell flow cytometry crossmatch-positive patients.
Terasaka S; Kitada H; Okabe Y; Kawanami S; Noguchi H; Miyamoto K; Tsuchimoto A; Masutani K; Tanaka M
Exp Clin Transplant; 2014 Jun; 12(3):227-32. PubMed ID: 24907723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
